Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 707

1.

A dedicated inflammatory bowel disease service quantitatively and qualitatively improves outcomes in less than 18 months: a prospective cohort study in a large metropolitan centre.

Phan VH, van Langenberg DR, Grafton R, Andrews JM.

Frontline Gastroenterol. 2012 Jul;3(3):137-142. doi: 10.1136/flgastro-2011-100086. Epub 2012 May 1.

2.

Genetic polymorphisms of MAFK, encoding a small Maf protein, are associated with susceptibility to ulcerative colitis in Japan.

Arisawa T, Nakamura M, Otsuka T, Jing W, Sakurai N, Takano H, Hayashi T, Ota M, Nomura T, Hayashi R, Shimasaki T, Tahara T, Shibata T.

World J Gastroenterol. 2017 Aug 7;23(29):5364-5370. doi: 10.3748/wjg.v23.i29.5364.

3.

Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis.

Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Murata M.

Int J Mol Sci. 2017 Aug 19;18(8). pii: E1808. doi: 10.3390/ijms18081808. Review.

4.

[NOD2 gene mutation in Moroccan patients with Crohn's disease: prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn's disease].

Tamzaourte M, Errabih I, Krami H, Maha F, Maria L, Benzzoubeir N, Ouazzani L, Sefiani A, Ouazzani H.

Pan Afr Med J. 2017 Jun 14;27:116. doi: 10.11604/pamj.2017.27.116.9187. eCollection 2017. French.

5.

Early histological findings may predict the clinical phenotype in Crohn's colitis.

Klein A, Mazor Y, Karban A, Ben-Itzhak O, Chowers Y, Sabo E.

United European Gastroenterol J. 2017 Aug;5(5):694-701. doi: 10.1177/2050640616676435. Epub 2016 Oct 21.

6.

Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.

El-Salhy M, Solomon T, Hausken T, Gilja OH, Hatlebakk JG.

World J Gastroenterol. 2017 Jul 28;23(28):5068-5085. doi: 10.3748/wjg.v23.i28.5068. Review.

7.

A randomized clinical trial of vitamin D3 (cholecalciferol) in ulcerative colitis patients with hypovitaminosis D3.

Mathur J, Naing S, Mills P, Limsui D.

PeerJ. 2017 Aug 3;5:e3654. doi: 10.7717/peerj.3654. eCollection 2017.

8.

Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis.

Wang Y, Liu L, Guo Y, Mao T, Shi R, Li J.

Exp Ther Med. 2017 Aug;14(2):1327-1336. doi: 10.3892/etm.2017.4701. Epub 2017 Jun 28.

9.

Managing Crohn's Disease during Pregnancy.

Cimpoca BA, Nedelea F, Furtuna M, Peltecu G, Panaitescu AM.

Maedica (Buchar). 2016 Sep;11(3):221-226.

10.

Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells.

Auci DL, Egilmez NK.

J Gastroenterol Pancreatol Liver Disord. 2016;3(4). doi: 10.15226/2374-815X/3/4/00166. Epub 2016 Aug 11. No abstract available.

11.

Fibroblast Growth Factor 21 Deficiency Attenuates Experimental Colitis-Induced Adipose Tissue Lipolysis.

Liu L, Zhao C, Yang Y, Kong X, Shao T, Ren L, Zhuang X, Yin B, Dryden G, McClain C, Luan W, Feng W.

Gastroenterol Res Pract. 2017;2017:3089378. doi: 10.1155/2017/3089378. Epub 2017 May 11.

12.

Inflammatory bowel disease in liver transplanted patients.

Filipec Kanizaj T, Mijic M.

World J Gastroenterol. 2017 May 14;23(18):3214-3227. doi: 10.3748/wjg.v23.i18.3214. Review.

13.

Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases.

Plaza-Díaz J, Ruiz-Ojeda FJ, Vilchez-Padial LM, Gil A.

Nutrients. 2017 May 28;9(6). pii: E555. doi: 10.3390/nu9060555. Review.

14.

Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial.

Kedia S, Bhatia V, Thareja S, Garg S, Mouli VP, Bopanna S, Tiwari V, Makharia G, Ahuja V.

World J Gastrointest Pharmacol Ther. 2017 May 6;8(2):147-154. doi: 10.4292/wjgpt.v8.i2.147.

15.

Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function.

Manresa MC, Taylor CT.

Cell Mol Gastroenterol Hepatol. 2017 Feb 20;3(3):303-315. doi: 10.1016/j.jcmgh.2017.02.004. eCollection 2017 May. Review.

16.

Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis.

Celiberto LS, Bedani R, Dejani NN, Ivo de Medeiros A, Sampaio Zuanon JA, Spolidorio LC, Tallarico Adorno MA, Amâncio Varesche MB, Carrilho Galvão F, Valentini SR, Font de Valdez G, Rossi EA, Cavallini DCU.

PLoS One. 2017 Apr 24;12(4):e0175935. doi: 10.1371/journal.pone.0175935. eCollection 2017.

17.

Schiff base complexes of copper and zinc as potential anti-colitic compounds.

Conner EM, Reglinski J, Smith WE, Zeitlin IJ.

Biometals. 2017 Jun;30(3):423-439. doi: 10.1007/s10534-017-0016-z. Epub 2017 Apr 19.

18.

Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response.

Bhaumik S, Basu R.

Front Immunol. 2017 Mar 31;8:254. doi: 10.3389/fimmu.2017.00254. eCollection 2017. Review.

19.

Frequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases.

Tsuchiya K, Ikeda T, Batmunkh B, Choijookhuu N, Ishizaki H, Hotokezaka M, Hishikawa Y, Nanashima A.

Acta Histochem Cytochem. 2017 Feb 28;50(1):21-28. doi: 10.1267/ahc.16035. Epub 2017 Feb 22.

20.

Ficolin-A/2, acting as a new regulator of macrophage polarization, mediates the inflammatory response in experimental mouse colitis.

Yang YF, Zhou YD, Hu JC, Luo FL, Xie Y, Shen YY, Bian WX, Yin ZN, Li HL, Zhang XL.

Immunology. 2017 Aug;151(4):433-450. doi: 10.1111/imm.12741. Epub 2017 May 15.

PMID:
28380665

Supplemental Content

Support Center